Gritstone Bio Inc
NASDAQ:GRTS 4:00:00 PM EDT
| Market Cap (Intraday) | 79.32M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.86 |
| 50-Day MA | $1.93 |
| 200-Day MA | $1.92 |
Gritstone Bio Inc Stock, NASDAQ:GRTS
5959 Horton Street, Suite 300, Emeryville, California 94608
United States of America
Phone: +1.510.871.6100
Number of Employees: 231
Description
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.